Ascendiant Capital Maintains Buy on Aemetis, Lowers Price Target to $19
Portfolio Pulse from Benzinga Newsdesk
Ascendiant Capital has maintained a Buy rating on Aemetis (NASDAQ:AMTX) but has lowered the price target from $20 to $19.
September 03, 2024 | 9:59 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Ascendiant Capital has maintained a Buy rating on Aemetis but reduced the price target from $20 to $19, indicating a slightly less optimistic outlook.
The maintenance of a Buy rating suggests continued confidence in Aemetis, but the lowered price target indicates a slightly reduced expectation for future performance. This mixed signal may result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100